Business
Taysha Gene Therapies to Participate in Upcoming October Investor Healthcare Conferences
Chardan’s 5th Annual Genetic Medicines Conference on October 5 at 1:30 pm ET President, Founder and Chief Executive Officer to participate in the “What’s
About this update from Taysha Gene Therapies, Inc.
[{"type":"text","content":"\nChardan’s 5th Annual Genetic Medicines Conference on October 5 at 1:30 pm ET\n\nPresident, Founder and Chief Executive Officer to participate in the “What’s Next for Advanced Therapies” panel at Meeting on the Mesa on October 12, 2021 at 7:15 am PT\n\nChief Medical Officer and Head of R&D to deliver corporate presentation at Meeting on the Mesa on October 12, 2021 at 2:30 pm PT\n\n DALLAS--(BUSINESS WIRE)--\nTaysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) in both rare and large patient populations, today announced its participation in a fireside chat at Chardan’s 5th Annual Genetic Medicines Conference and a panel discussion and corporate presentation at the Cell & Gene Meeting on the Mesa on October 12, 2021. Meeting on the Mesa is the largest annual partnering meeting dedicated solely to the cell and gene therapy sector, attracting more than 1,200 attendees through the three-day program and featuring presentations and talks by major companies in the space.\n\nThe “What’s Next for Advanced Therapies” panel will feature leading executives in the advanced therapies medicinal product (ATMP) space who will discuss a number of topics including recent advancements in clinical trials, going from treating rare diseases to prevalent conditions and implementing next-generation gene-editing technologies. The session will also touch upon resolving manufacturing and talent bottlenecks as the sector moves towards commercialization, as well as the evolution of reimbursement payment models.\n\n\n\nConference Details:\n\n\n\n\n\nEvent:\n\n\n\n“Chardan’s 5th Annual Genetic Medicines Conference\n\n\n\n\n\nDate:\n\n\n\nOctober 5, 2021\n\n\n\n\n\nTime:\n\n\n\n1:30 pm ET\n\n\n\n\n\nFormat:\n\n\n\nFireside Chat\n\n\n\n\n\nParticipants:\n\n\n\nRA Session II, President, Founder and CEO\n\n\n\n\n\n \n\n\n\nDr. Suyash Prasad, Chief Medical Officer and Head of R&D\n\n\n\n\n\n \n\n\n\nKamran Alam, Chief Financial Officer\n\n\n\n\n\n \n\n\n\nKimberly Lee, SVP, Corporate Communications and Investor Relations\n\n\n\n\n\n \n\n\n\n \n\n\n\n\n\nPanel Details:\n\n\n\n\n\nEvent:\n\n\n\nMeeting on the Mesa\n\n\n\n\n\nTopic:\n\n\n\n“What’s Next for Advanced Therapies”\n\n\n\...